Immunotech Laboratories, Inc.

IMMB · OTC
Analyze with AI
12/31/2016
9/30/2016
6/30/2016
9/30/2006
Operating Activities
Net Income-$152
Dep. & Amort.$0
Deferred Tax$0
Stock-Based Comp.$0
Change in WC$83
Other Non-Cash$0
Operating Cash Flow-$68
Investing Activities
PP&E Inv.-$113
Net Acquisitions$0
Inv. Purchases$0
Inv. Sales/Matur.$0
Other Inv. Act.$0
Investing Cash Flow-$113
Financing Activities
Debt Repay.$261
Stock Issued$0
Stock Repurch.$0
Dividends Paid$0
Other Fin. Act.-$76
Financing Cash Flow$185
Forex Effect$0
Net Chg. in Cash$4
Supplemental Information
Beg. Cash$15
End Cash$19
Free Cash Flow-$181